Capecitabine and the Risk of Fingerprint Loss

JAMA Oncol. 2017 Jan 1;3(1):122-123. doi: 10.1001/jamaoncol.2016.2638.
No abstract available

MeSH terms

  • Capecitabine / adverse effects*
  • Capecitabine / therapeutic use
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / pathology
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Dermatoglyphics
  • Female
  • Fluorouracil / adverse effects
  • Hand-Foot Syndrome / etiology
  • Hand-Foot Syndrome / pathology
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology
  • Male
  • Skin Diseases, Genetic / chemically induced
  • Skin Diseases, Genetic / pathology*

Substances

  • Capecitabine
  • Fluorouracil

Supplementary concepts

  • Fingerprints, Absence of